NCT07220096 Registry Trial and Needs Assessment of Patients With Young-onset Lung Cancer: Impact of a Dedicated Care Program on Patient Experience and Outcomes
| NCT ID | NCT07220096 |
| Status | Recruiting |
| Phase | — |
| Sponsor | M.D. Anderson Cancer Center |
| Condition | Lung Cancer |
| Study Type | OBSERVATIONAL |
| Enrollment | 75 participants |
| Start Date | 2025-09-25 |
| Primary Completion | 2029-05-31 |
Eligibility & Interventions
Eligibility Fast-Check
Enter your details for a quick preliminary check. This does not replace medical advice.
What to Expect as a Participant
This is an observational study. You will not receive an experimental treatment; researchers will collect data based on your existing condition or standard treatment.
This trial targets 75 participants in total. It began in 2025-09-25 with a primary completion date of 2029-05-31.
⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.
Brief Summary
The goal of this research study is to learn about: The effect of enrolling in the YOLC program on patient satisfaction with care provided, The needs of patients younger than 50 with lung cancer and their family, and The impact of participating in peer support networks on these patients.
Eligibility Criteria
Inclusion Criteria: * Age greater than 18 years and under 50 years * Histologic confirmation of NSCLC * Able to complete an English-language survey independently or with the assistance of a native-language interpreter * Pregnant women- may be enrolled due to age range of subjects. (Low risk) Exclusion Criteria: * Medical, psychiatric, cognitive, or other conditions that compromise the patient's ability to understand the patient information, to give informed consent, to comply with the study protocol or to complete the study. * The following special patient population will be excluded from study group: * Individuals who are not yet adults (infants, children, teenagers) * Prisoners * Cognitively-impaired adults
Contact & Investigator
Eric Singhi, MD
PRINCIPAL INVESTIGATOR
M.D. Anderson Cancer Center
Frequently Asked Questions
Who can join the NCT07220096 clinical trial?
This trial is open to participants of all sexes, aged 18 Years or older, up to 50 Years, studying Lung Cancer. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.
Is NCT07220096 currently recruiting?
Yes, NCT07220096 is actively recruiting participants. Contact the research team at eksinghi@mdanderson.org for enrollment information.
Where is the NCT07220096 trial being conducted?
This trial is being conducted at Houston, United States.
Who is sponsoring the NCT07220096 clinical trial?
NCT07220096 is sponsored by M.D. Anderson Cancer Center. The principal investigator is Eric Singhi, MD at M.D. Anderson Cancer Center. The trial plans to enroll 75 participants.
Related Trials
Related Intelligence Guides
In-depth guides covering this condition's trials, eligibility, and what to expect.